# CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM – NICHD CONTRACEPTIVE CLINICAL TRIALS NETWORK, FEMAILE SITES-CORE FUNCTION ACTIVITIES

> **NIH NIH N02** · BOSTON MEDICAL CENTER · 2020 · $13,265

## Abstract

There is a demand for new methods of contraception that can provide effective protection against unintended pregnancy as well as reduce the risk of venous thromboembolism (VTE), particularly for obese women. The mission of the Contraceptive Clinical Trials Network (CCTN) is to develop protocols and conduct clinical trials that will assist in product development with the end goal to provide effective and safe contraception for women.
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) has a mission to develop safe and effective contraceptives for women, including obese women and women who have medical conditions for which current contraceptive products are contraindicated.

## Key facts

- **NIH application ID:** 10232626
- **Project number:** 75N94020D00004-0-759402000001-1
- **Recipient organization:** BOSTON MEDICAL CENTER
- **Principal Investigator:** KATHARINE WHITE
- **Activity code:** N02 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $13,265
- **Award type:** —
- **Project period:** 2020-08-01 → 2021-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10232626

## Citation

> US National Institutes of Health, RePORTER application 10232626, CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM – NICHD CONTRACEPTIVE CLINICAL TRIALS NETWORK, FEMAILE SITES-CORE FUNCTION ACTIVITIES (75N94020D00004-0-759402000001-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10232626. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*